Boehringer Ingelheim International GmbH
Bristol Myers Squibb Company
Cipla Limited
FibroGen Inc. Horizon Therapeutics Public Limited Company
Jubilant Pharma Limited
MediciNova Inc. Merck & Co. Inc. Roche Holding AG
United Therapeutics Corporation
Published | Pages | Publisher | Report code |
---|---|---|---|
Dec 2022 | 79 | GEN Consulting | ASDR-612852 |
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Company
Cipla Limited
FibroGen Inc. Horizon Therapeutics Public Limited Company
Jubilant Pharma Limited
MediciNova Inc. Merck & Co. Inc. Roche Holding AG
United Therapeutics Corporation